Premium
Targeted therapy in prostate cancer—Are we our own worst enemy?
Author(s) -
Dawson Nancy A.
Publication year - 2008
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.23865
Subject(s) - medicine , prostate cancer , cancer , prostate , targeted therapy , oncology
Targeted therapies are being assessed in castrate‐resistant prostate cancer, but their development is slow, and the correct targets are not always clear. Given the propensity for prostate cancer to metastasize to bone, therapies that target the bone microenvironment are a logical choice.